CAS 85933-19-3
:Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Carbidopa Related Compound A (3-O-Methylcarbidopa)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C11H16N2O4Color and Shape:Yellow Tan PowderMolecular weight:240.11101rac-Carbidopa EP Impurity C (Carbidopa USP Related Compound A)
CAS:Formula:C11H16N2O4Molecular weight:240.26rac-Carbidopa EP Impurity C Trifluoroacetate (Carbidopa USP Related Compound A Trifluoroacetate)
CAS:Formula:C11H16N2O4·C2HF3O2Color and Shape:White To Off-White SolidMolecular weight:240.26 114.02rac-Carbidopa EP Impurity C (Carbidopa USP Related Compound A)
CAS:Controlled ProductFormula:C11H16N2O4Color and Shape:NeatMolecular weight:240.263-O-Methyl Carbidopa
CAS:<p>Applications 3-O-Methylcarbidopa is an impurity of Carbidopa (C175915) with potential use as therapeutic agents to treat hypertension and Parkinson's disease.<br>References Gelber, L. et al.: J. Chrom., 257, 317 (1983); Kallwass, H. et al.: Bioorg. Med. Chem., 2, 557 (1994);<br></p>Formula:C11H16N2O4Color and Shape:NeatMolecular weight:240.263-O-Methyl carbidopa
CAS:Controlled Product<p>3-O-Methyl carbidopa is a metabolite of L-3,4-dihydroxyphenylalanine that is used as a drug in the treatment of Parkinson's disease. 3-O-Methyl carbidopa is a racemic mixture of two stereoisomers that have different chemical properties. The (+) form is more active and has been shown to be more potent than the (-) form. Analysis of this compound by magnetic resonance spectroscopy (NMR) at different magnetic fields showed that it has six distinct resonances: three from the protonated molecule and three from the deprotonated molecule. The proton nmr spectrum showed peaks at 2.02 ppm (D1), 2.81 ppm (D2), 3.84 ppm (D3), 4.07 ppm (D4), 4.28 ppm (D5), and 4.53 ppm (D6). These peaks correspond to resonances for protons</p>Formula:C11H16N2O4Purity:Min. 95%Color and Shape:PowderMolecular weight:240.26 g/mol
